Free, publicly available health data proves to be research gold mine

Free, publicly available health data proves to be research gold mine
From left: Pinaki Bose and Lubaba (Aurna) Khan sourced big data to try to explain why some cancer patients respond to immunotherapy while others do not. The findings are published in Nature Communications. Credit: Riley Brandt, University of Calgary

It's a popular question: What did you do over the summer? For Lubaba (Aurna) Khan, the summer of 2018 will be one she will never forget.

It started on a high note and ended on an even higher one. In June, Khan walked across the stage to accept her degree as a University of Calgary Bachelor of Health Sciences graduate. She received an O'Brien Centre Summer Studentships award, landing a research job with Dr. Pinaki Bose, Ph.D. Then, unexpectedly, she made a discovery that could help cancer patients throughout the world.

Khan spent the summer hunched over a computer interpreting free, publicly accessible health and genomics data. "Bioinformatics is the new frontier of medical science," says Khan. "I started my as a biomedical student, looking at cells through a microscope, but looking at with the assistance of a computer opens up a new way of thinking about research."

Khan was comparing the differences between genes found in and those found in normal cells. Working under the guidance of Bose, Khan learned how to construct questions and hypotheses. It was a bumpy start.

"We wanted to find out how immune genes in cancer cells might be associated with response. There was nothing there, and we were disappointed," says Bose, who is an adjunct assistant professor in the departments of biochemistry and , and oncology, and is a member of the Arnie Charbonneau Cancer Institute at the Cumming School of Medicine.

"We adjusted our focus, and discovered that another set of genes, those associated with the extracellular matrix, had a direct connection to how respond to immunotherapy."

Immunotherapy has become a popular treatment for some cancers. It uses the body's own immune system to attack and kill cancer cells. The treatment is effective, but only for a select few, around 20 to 30 per cent of patients. There is not a clear understanding as to why some people respond better to immunotherapy than others.

The extracellular matrix may hold some of the answers; it grows within and around both healthy and cancerous cells.

"We found that genes associated with the are overly produced in patients who do not respond to immunotherapy," says Bose, who is also the director of translational research for the Ohlson Research Initiative. "These are produced by cells surrounding the tumour, and they form a barrier which helps cancer evade detection by the immune system."

The UCalgary team shared the discovery with researchers at the University of Toronto who have validated the findings, now published in Nature Communications. "I was like, wow, I'm a student. I didn't realize how important this was until Dr. Bose pointed out how significant this discovery could be in treatment. It kind of threw me off, but I was extremely excited at the same time," says Khan, who is a co-first author on the study.

The researchers looked more deeply at their findings and discovered a gene signature, which could lead to the development of a simple test that could help determine which patients would benefit from immunotherapy. The next step will be to prove the findings in a lab.

"Analyzing won't replace bench science, but it a great tool for hypothesis-building and leading to new insights," says Bose.

For Khan, this experience has changed the course of her future studies. She always planned to pursue a master's degree in public health, and now sees a future focused on data analysis rather than data collection.


Explore further

Gene signature discovery may predict response to immune therapy

More information: TGF-β-associated extracellular matrix genes link cancer-associated fibroblasts to immune evasion and immunotherapy failure, Nature Communications (2018). DOI: 10.5281/zenodo.1410639 , https://www.nature.com/articles/s41467-018-06654-8
Provided by University of Calgary
Citation: Free, publicly available health data proves to be research gold mine (2018, December 3) retrieved 23 February 2019 from https://medicalxpress.com/news/2018-12-free-publicly-health-gold.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
61 shares

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more